Memantine Hydrochloride Tablet, Film Coated
FDA Label NDC 70771-1119

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Memantine Hydrochloride (NDC 70771-1119). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1119-1 in bottle of 100 tablets

Memantine Hydrochloride Tablets USP, 5 mg

Rx only

100 tablets

Memantine Hydrochloride Tablets (Dd8e677c B9da 439e Bdaf 36dfaa3b5b07 10)

Memantine Hydrochloride Tablets (Dd8e677c B9da 439e Bdaf 36dfaa3b5b07 10)

NDC 70771-1120-1 in bottle of 100 tablets

Memantine Hydrochloride Tablets USP, 10 mg

Rx only

100 tablets

Memantine Hydrochloride Tablets (Dd8e677c B9da 439e Bdaf 36dfaa3b5b07 11)

Memantine Hydrochloride Tablets (Dd8e677c B9da 439e Bdaf 36dfaa3b5b07 11)

* Please review the disclaimer below.